Levonorgestrel-releasing Intrauterine device is advised in fibroid management if uterine size is less than
First, I need to recall the core concept. The LNG-IUD, like Mirena, releases a progestin that reduces menstrual bleeding and can also help manage fibroids. But there's a size limit because the device needs to fit properly and function effectively.
The correct answer is probably related to uterine size. I remember that the LNG-IUD is suitable for women with a uterus smaller than a certain size, maybe 12 weeks or 14 weeks. Wait, I think it's 12 weeks. Let me confirm. The standard guideline I studied mentioned that LNG-IUD is advised if the uterus is less than 12 weeks in size. If the uterus is larger, the device might not stay in place or could cause complications.
Now, the options are A, B, C, D, but the values aren't given here. Wait, the user provided the question but didn't list the options. That's a problem. How can I explain the wrong options if I don't know what they are? Maybe the original question had specific numbers, like 10, 12, 14 weeks. Since the correct answer is less than 12 weeks, the other options would be higher numbers. For example, if the options were A: 10 weeks, B: 12 weeks, C: 14 weeks, D: 16 weeks, then B is correct. But without knowing the actual options, it's hard. Wait, the user's correct answer is missing the letter and text. The original question must have had options like A. 10 weeks, B. 12 weeks, etc. So the correct answer is B. 12 weeks.
So, in my explanation, I need to state that the LNG-IUD is advised if the uterus is less than 12 weeks. The mechanism is that the progestin reduces endometrial proliferation and bleeding, which helps with fibroid symptoms. The wrong options would be larger sizes where the device isn't suitable. The clinical pearl would be to remember the 12-week size limit for LNG-IUD in fibroid management. Also, note that larger fibroids might require other treatments like myomectomy or uterine artery embolization.
**Core Concept**
The Levonorgestrel-releasing intrauterine device (LNG-IUD) is contraindicated for fibroid management in uteri larger than 12 weeks' gestational size due to increased risk of expulsion and inadequate device positioning. Progestin reduces endometrial proliferation and bleeding, but mechanical factors limit its use in enlarged uteri.
**Why the Correct Answer is Right**
The LNG-IUD (e.g., Mirena) is effective for fibroid-related menorrhagia only if the uterine cavity volume is **<12 weeks** (≈120 mL). Beyond this size, fibroid bulk or uterine distortion may prevent proper device placement or retention. Progestin’s mechanism involves thinning the endometrium and reducing vascularity, but it does not shrink fibroids themselves.
**Why Each